127 related articles for article (PubMed ID: 6156028)
21. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
van Trommel NE; Sweep FC; Schijf CP; Massuger LF; Thomas CM
Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
[TBL] [Abstract][Full Text] [Related]
22. Concentrations of human choriogonadotropin, its beta-subunit, and the core fragment of the beta-subunit in serum and urine of men and nonpregnant women.
Alfthan H; Haglund C; Dabek J; Stenman UH
Clin Chem; 1992 Oct; 38(10):1981-7. PubMed ID: 1382894
[TBL] [Abstract][Full Text] [Related]
23. In vivo release of beta human chorionic gonadotropin by luteinizing hormone releasing hormone stimulation and its clinical application as a remission criterion in patients with gestational trophoblastic disease.
Kim SJ; Jung JK; Kang BC; Namkoong SE; Lee JW
Int J Gynaecol Obstet; 1988 Oct; 27(2):193-8. PubMed ID: 2460385
[TBL] [Abstract][Full Text] [Related]
24. Falsely decreased human chorionic gonadotropin (hCG) results due to increased concentrations of the free beta subunit and the beta core fragment in quantitative hCG assays.
Grenache DG; Greene DN; Dighe AS; Fantz CR; Hoefner D; McCudden C; Sokoll L; Wiley CL; Gronowski AM
Clin Chem; 2010 Dec; 56(12):1839-44. PubMed ID: 20930131
[TBL] [Abstract][Full Text] [Related]
25. Alpha subunit of glycoprotein hormone: presence in peripheral serum after LHRH.
Benveniste R; Frohman LA; Bell J; Spitz I; Rabinowitz D
Eur J Clin Invest; 1975 Apr; 5(2):123-31. PubMed ID: 50235
[TBL] [Abstract][Full Text] [Related]
26. [Fundamental evaluation of ELSA.F-beta HCG kit as an immunoradiometric assay specific for serum beta HCG].
Omori S; Suehiro M; Fukuchi M
Kaku Igaku; 1992 Jun; 29(6):709-16. PubMed ID: 1379310
[TBL] [Abstract][Full Text] [Related]
27. Evaluating human choriogonadotropin heterogeneity in nongestational malignancy with monoclonal immunoassays.
Hay DL; Murphy JR
Oncology; 1987; 44(3):174-9. PubMed ID: 2439967
[TBL] [Abstract][Full Text] [Related]
28. Nature of cross-reaction between hCG and anti-oLH serum and development of a radioimmunoassay to measure hLH specifically in the presence of hCG.
Dattatreyamurty B; Sheth AR; Purandare TV; Rao SS
Endocrinology; 1976 Dec; 99(6):1554-61. PubMed ID: 63368
[TBL] [Abstract][Full Text] [Related]
29. Highly sensitive radioimmunoassay for chorionic gonadotropin in human urine.
Ayala AR; Nisula BC; Chen HC; Hodgen GD; Ross GT
J Clin Endocrinol Metab; 1978 Oct; 47(4):767-73. PubMed ID: 95624
[TBL] [Abstract][Full Text] [Related]
30. Polypeptide nicks cause erroneous results in assays of human chorionic gonadotropin free beta-subunit.
Kardana A; Cole LA
Clin Chem; 1992 Jan; 38(1):26-33. PubMed ID: 1370771
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal versus polyclonal antibody radioimmunoassay against the beta-subunit of human chorionic gonadotropin in patients with gestational trophoblastic neoplasia.
Wu T; Ballon SC; Teng NN
Am J Obstet Gynecol; 1983 Dec; 147(7):821-5. PubMed ID: 6196974
[TBL] [Abstract][Full Text] [Related]
32. Development of colorimetric enzyme-linked immunosorbent assay for human chorionic gonadotropin.
Prasad PV; Chaube SK; Shrivastav TG; Kumari GL
J Immunoassay Immunochem; 2006; 27(1):15-30. PubMed ID: 16450866
[TBL] [Abstract][Full Text] [Related]
33. Effect of variations in globulin concentrations on serum radioimmunoassay results, as exemplified by choriogonadotropin.
Jawad MJ; Wilson EA
Clin Chem; 1981 Dec; 27(12):1993-6. PubMed ID: 6171362
[TBL] [Abstract][Full Text] [Related]
34. Clinical comparison of immunoradiometric assays for intact versus beta-specific human chorionic gonadotropin.
Pardue MG; Taylor EH; London S; Walls RC; Pappas AA
Am J Clin Pathol; 1990 Mar; 93(3):347-51. PubMed ID: 1689940
[TBL] [Abstract][Full Text] [Related]
35. Radioimmunoassay of free beta-subunit of human chorionic gonadotropin in diagnosis of high-risk and low-risk gestational trophoblastic disease.
Khazaeli MB; Buchina ES; Pattillo RA; Soong SJ; Hatch KD
Am J Obstet Gynecol; 1989 Feb; 160(2):444-9. PubMed ID: 2464935
[TBL] [Abstract][Full Text] [Related]
36. The Stratus immunofluorometric assay system evaluated for quantifying human choriogonadotropin in serum.
Rogers LC; Kahn SE; Oeser TH; Bermes EW
Clin Chem; 1986 Jul; 32(7):1402-4. PubMed ID: 3013465
[TBL] [Abstract][Full Text] [Related]
37. Immunoassays for quantifying choriogonadotropin compared for assay performance and clinical application.
Witherspoon LR; Shuler SE; Joseph GF; Baird EF; Neely HR; Sonnemaker RE
Clin Chem; 1992 Jun; 38(6):887-94. PubMed ID: 1375877
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of a solid-phase enzyme immunoassay for human choriogonadotropin beta subunit.
Davey DD; Sample MM; Oei TO
Clin Chem; 1983 Nov; 29(11):1964-6. PubMed ID: 6194917
[TBL] [Abstract][Full Text] [Related]
39. Cross-reactivity of a commercial chemiluminescence immunoassay for human chorionic gonadotropin with the free beta-subunit.
Luppa P; Spöttl G; Saller B; Neumeier D; Mann K
J Biolumin Chemilumin; 1992 Jul; 7(3):195-201. PubMed ID: 1381136
[TBL] [Abstract][Full Text] [Related]
40. Fibrocystic breast disease: the significance of beta-human chorionic gonadotropin and other polypeptides in breast cyst fluid.
Abney TO; Teran AZ; Mahesh VB; Mullins WB; Greenblatt RB
Fertil Steril; 1988 Apr; 49(4):638-43. PubMed ID: 2450789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
